Business Class
Pharmacy or ‘phactory’
Is your pharmacy really about patients and their care or is it a script processing factory/‘phactory’ for them? While there is strong evidence of organised production during ancient and medieval …
Budget delivers ‘wins’ for pharmacy
Pharmacy owners will have plenty to think about following last week’s Federal Budget, Marcus Evitt of Peak Strategies says Labour Treasurer, Jim Chalmers has released the 2024-2025 federal budget, focusing …
‘Now is the time to review your business’
Major changes to the Pharmacy Business Ownership Act 2024 will have several impacts on Queensland pharmacy owners, writes Lachlan Ballinger In December 2023, the Queensland Government took a significant step …
Decoding data for success
Having data-informed marketing strategy and analysis is essential for getting the best outcomes, says Sarah Rendell When it comes to pharmacists and marketing, I often come across this common assumption …
Full scope of practice: Mirage or oasis?
Full scope of practice has been touted as a panacea for pharmacy. Is it the lush oasis of the promised land, or merely a dusty mirage? A few decades ago, …
Fringe Benefits Tax
Pharmacy owners need to be mindful of fringe benefits tax (FBT) when providing employees with incentives, writes Victoria Le With the current market of finding good employees and providing benefits …
Navigating the rental squeeze
You need to understand the impact of CPI on retail shop leases, says Phil Chapman, using insights from the March 2024 quarter The latest release from the Australian Bureau of …
60 day dispensing KPIs
Over six months have passed since the implementation of sixty-day dispensing. It’s time to start monitoring your pharmacy’s performance during the transition, says Victoria Le In a recent LinkedIn video, …
Dealing with pharmacy’s ‘Bermuda Triangle’
Pharmacy owners must make sure that their space investment works well, but are they stocking the right categories to maximise their returns? Bermuda is a British overseas territory in the …
Investment ratings houses cool on Sigma/CWH deal
Evidence is growing that some institutional advisors may be starting to grow wary of the CWH/Sigma deal, says Mike Taylor When financial advisers make investment recommendations to clients they are …
Improving your patient engagement and experience
Transformational vs transactional : how would your customers describe their visit to your pharmacy? Glenn Guilfoyle and Marta Stybowski break down the steps to ensuring a better patient experience One …
Price pressures
What are the 5 key forces at play in the current pharmacy market? Natalie Sirianni explains The last 5 years Over the last five or so years, we have seen …